Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening Program

被引：0
|
作者：
Kenneth Elder
Carolyn Nickson
Melinda Pattanasri
Samuel Cooke
Dorothy Machalek
Allison Rose
Arlene Mou
John Paxton Collins
Allan Park
Richard De Boer
Claire Phillips
Vicki Pridmore
Helen Farrugia
G. Bruce Mann
机构：
[1] Royal Melbourne and Royal Women’s Hospital,The Breast Service
[2] The University of Melbourne,Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health
[3] The University of Melbourne,Department of Surgery
[4] BreastScreen Victoria,undefined
[5] Victorian Cancer Registry,undefined
[6] Cancer Council New South Wales,undefined
来源：
Annals of Surgical Oncology | 2018年 / 25卷
关键词：
Breast Cancer; Early-stage Breast Cancer (ESBC); Postmastectomy Radiotherapy; Risk Ratio (RR); Screen-detected Cancers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2563 / 2572
页数：9
相关论文
共 50 条
  • [1] Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening Program
    Elder, Kenneth
    Nickson, Carolyn
    Pattanasri, Melinda
    Cooke, Samuel
    Machalek, Dorothy
    Rose, Allison
    Mou, Arlene
    Collins, John Paxton
    Park, Allan
    De Boer, Richard
    Phillips, Claire
    Pridmore, Vicki
    Farrugia, Helen
    Mann, G. Bruce
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (09) : 2563 - 2572
  • [2] Treatment intensity differences in screen-detected and community-detected early stage breast cancer (ESBC)
    Elder, Kenneth Jack
    Cooke, Samuel
    Machalek, Dorothy
    Rose, Allison
    Mou, Arlene
    Collins, John Paxton
    Nickson, Carolyn
    Park, Allan
    Mann, Bruce
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Chemotherapy (CTX) treatment patterns for early-stage breast cancer (ESBC): Changing use of anthracyclines (A)
    Serrurier, Katherine M.
    Hwang, Jimmy
    McGuire, Joseph P.
    Lichtensztajn, Daphne
    Griffin, Ann C.
    Gomez, Scarlett Lin
    Kurian, Allison W.
    Melisko, Michelle E.
    Rugo, Hope S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Factors associated with reduced dose intensity in patients receiving adjuvant chemotherapy for early-stage breast cancer (ESBC).
    Lyman, GH
    Wolff, DA
    Culakova, E
    Poniewierski, A
    Dale, DC
    Crawford, J
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S60 - S60
  • [5] Current patterns of chemotherapy and supportive care for early-stage breast cancer (ESBC).
    Lyman, Gary H.
    Dale, David C.
    Tomita, Dianne
    Whittaker, Sadie
    Crawford, Jeffrey
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Cumulative prevalence of anemia in early-stage breast cancer (ESBC) patients.
    Lawless, GD
    Ford, JM
    [J]. BLOOD, 2000, 96 (11) : 390B - 390B
  • [7] Osteoporosis after adjuvant treatment for early-stage breast cancer
    Christensen, Carina Orts
    Jensen, Maj-Britt
    Hermann, Anne Pernille
    Ewertz, Marianne
    [J]. DANISH MEDICAL JOURNAL, 2020, 67 (11):
  • [8] Chemotherapy treatment patterns for early-stage breast cancer (ESBC): Decreasing use of anthracycline-based regimens
    Serrurier, Katherine M.
    Hwang, Jimmy
    McGuire, Joseph P.
    Griffin, Ann C.
    Melisko, Michelle E.
    Rugo, Hope S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [9] Employment participation after early-stage breast cancer: Patterns and determinants.
    Ekenga, Christine C.
    Perez, Maria
    Margenthaler, Julie A.
    Jeffe, Donna B.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 176 - 177
  • [10] Minimally invasive approaches for diagnosis and treatment of early-stage breast cancer
    Vlastos, Georges
    Verkooijen, Helena M.
    [J]. ONCOLOGIST, 2007, 12 (01): : 1 - 10
12345